Pulmonx LUNG
NASDAQ LUNG
$2.32 +0.01 (+0.22%)
As of: Aug 20, 2026 · 3:59 PM EDT

Pulmonx (LUNG) Return on Invested Capital Growth (3y) (2024 - 2025)

Pulmonx (LUNG) Return on Invested Capital Growth (3y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC Growth (3y) (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 0.00
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 0.00
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 1.00
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 0.00
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -85.00
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 0.00
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 2.00
10 Pulmonx 93.95 Mn 24.20 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 2.00
Jun 30, 2025 3.00
Mar 31, 2025 3.00
Dec 31, 2024 1.00
Sep 30, 2024 3.00
Jun 30, 2024 20.00